Exocytosis is regulated by NO in many cell types, including neurons. In the present study we show that syntaxin 1a is a substrate for S-nitrosylation and that NO disrupts the binding of Munc18-1 to the closed conformation of syntaxin 1a in vitro. may be a molecular switch to disrupt Munc18-1 binding to the closed conformation of syntaxin 1a, thereby facilitating its engagement with the membrane fusion machinery.
INTRODUCTION
Exocytosis, the fusion of vesicles with the plasma membrane, can occur in a constitutive or regulated manner. In regulated exocytosis, fusion is generally triggered by an increase in the intracellular free Ca 2+ concentration, but further control is exerted by posttranslational modifications to the exocytotic machinery via intracellular messengers [1] . Indeed, PKC (protein kinase C) modulates Ca 2+ -triggered exocytosis in virtually all secretory cells via phosphorylation of multiple substrates [2] . For example, in adrenal chromaffin cells, the early stage of vesicle recruitment and the late stage of fusion pore expansion are regulated by phosphorylation of SNAP-25 (synaptosome-associated protein of 25 kDa) on Ser 187 and Munc18-1 on Ser 313 respectively [3, 4] . NO has also been shown to modulate exocytosis in a wide range of cell types, acting variously to stimulate (e.g. in brain synaptosomes [5] and pancreatic β-cells [6] ) or inhibit (e.g. in endothelial cells [7] and platelets [8] ) exocytosis. Again, multiple effects of NO are evident in adrenal chromaffin cells, where NO reduces the number of vesicles undergoing fusion, but also acts on a late stage in the exocytosis process to alter the kinetics and extent of transmitter release in the remaining fusion events [9] . It seems likely, therefore, that NO acts on more than one target to achieve these varied effects on exocytosis.
The classical mechanism of action of NO is to stimulate guanylate cyclase, with the consequent increased production of cGMP leading to the activation of protein kinase G and cyclic nucleotide-gated channels [10] . However S-nitrosylation, the direct post-translational modification of cysteine residues in proteins by NO, is an alternative physiological function of NO [11] . Although many of the reported effects of NO on exocytosis are mediated by cGMP, others are cGMP-independent. For example, the inhibitory effect of NO on exocytosis from platelets and endothelial cells is caused by S-nitrosylation [7, 8] . In both cases, S-nitrosylation of NSF is thought to inhibit exocytosis by preventing NSF-induced SNARE (soluble N-ethylmaleimidesensitive fusion protein-attachment protein receptor) complex disassembly [7, 12] .
Although NSF is an important target of NO in exocytosis, it is unlikely to be the only relevant S-nitrosylation substrate even in cells of the cardiovascular system [13] . Furthermore, the stimulatory effects of NO in neuronal/endocrine cells are difficult to reconcile with an inhibitory action on NSF. We therefore reasoned that other components of the conserved exocytosis machinery might be substrates for S-nitrosylation. In the present study we report that S-nitrosylation of Cys 145 in the SNARE protein, syntaxin 1a, acts as a molecular switch, turning off the Munc18-1 interaction mode that precludes SNARE complex formation, thereby facilitating interaction with the membrane fusion machinery.
MATERIALS AND METHODS

Materials
Unless otherwise stated, all materials were obtained from Sigma.
Plasmids
Plasmids encoding syntaxin 1a (residues 4-285) and GST (glutathione transferase)-syntaxin 1a (residues 4-266) were gifts from Abbreviations used: biotin-HPDP, N-[6-(biotinamido)hexyl]-3 -(2 -pyridyldithio)propionamide; DTT, dithiothreitol; EGFP, enhanced green fluorescent protein; EYFP, enhanced yellow fluorescent protein; FLIM, fluorescence lifetime imaging microscopy; FRET, Förster resonance energy transfer; GSNO, S-nitrosoglutathione; GST, glutathione transferase; HRP, horseradish peroxidase; MD, molecular dynamics; NEM, N-ethylmaleimide; NOR-1, 4-methyl-2-hydroxyimino-5-nitro-6-methoxy-3-hexenamide; NSF, NEM-sensitive fusion protein; PUFA, polyunsaturated fatty acid; SIN-1, S-morpholinosydnonimine; SM, Sec1/Munc18-like; SNAP-25, synaptosome-associated protein of 25 kDa; SNARE, soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptor; VAMP 2, vesicle-associated membrane protein 2. 1 To whom correspondence should be addressed (email amorgan@liverpool.ac.uk).
Dr R. Scheller (Genentech, San Francisco, CA, U.S.A.). Open (L165A/E166A) mutant versions of these plasmids have been previously described [14] . Cys 145 was mutated by site-directed mutagenesis in the GST-syntaxin 1a (4-266) construct for biochemical analyses and in the mCerulean-syntaxin 1a (1-288) construct [15] for live-cell imaging. For amperometry, the C145S and C145W mutations were introduced into full-length wildtype syntaxin 1a (1-288), which had been amplified by PCR from mouse brain cDNA and cloned into the expression vector pcDNA 3.1(−) (Invitrogen). The GST-complexin II plasmid was prepared by subcloning from pcDNA3-complexin II [16] into pGEX-4T (GE Healthcare). The pQE9-NSF plasmid encoding His-tagged NSF was a gift from Dr J. Rothman (Department of Physiology and Cellular Biophysics, Columbia University, New York, U.S.A.). Recombinant proteins were expressed and purified as previously described [14, [17] [18] [19] .
Detecting S-nitrosylation
Biotin-loss assays
Rat or bovine brain homogenates, prepared as described previously [20] , were dialysed against 10 mM Hepes (pH 7.4) and 0.1 mg/ml PMSF before an equal volume of 10 mM Hepes (pH 7.4), 0.2 M NaCl, 2 mM EDTA and 2 % (v/v) Triton X-100 was added. Following rotation for 4 h at 4
• C, the lysate was cleared by centrifugation for 1 h at 100 000 g at 4
• C. Protein S-nitrosylation was detected using the biotin-loss method [21] . Briefly, brain lysate or purified recombinant protein was mixed with HEN buffer [20 mM Hepes, 1 mM EDTA and 0.1 mM neocuproine (pH 7.4)], and incubated at room temperature (21
• C) with 1 mM GSNO (S-nitrosoglutathione) or NOR-1 (4-methyl-2-hydroxyimino-5-nitro-6-methoxy-3-hexenamide) for 45 min before addition of 0.5 mM biotin-HPDP {N- [6-(biotinamido) hexyl]-3 -(2 -pyridyldithio)propionamide} or biotin-BMCC {1-biotinamido-4[4 -(maleimidomethyl)cyclohexanecarboxamido]hexane} (both from Pierce) for 45 min. Following SDS/PAGE and transfer on to nitrocellulose, biotinylated proteins were detected using avidin-HRP (horseradish peroxidase) overlay.
Affinity purification Biotinylated brain lysate was acetone precipitated to remove excess unbound biotin and resuspended in HEN buffer with 1 % (v/v) Triton X-100. Biotinylated proteins were precipitated using neutravidin beads and detected by avidin overlay and Western blot analysis. Syntaxin 1 was immunoprecipitated from biotinylated brain lysate using the HPC-1 antibody and mouse IgG was used to control for non-specific binding. Samples were Western blotted with the HPC-1 antibody and subjected to avidin overlay to detect biotinylation.
Protein interaction studies
Bead-based binding assays GST-tagged proteins (20 μg) were bound to glutathione-coated beads for 1 h at 4
• C. Beads were washed with neutralization buffer [20 mM Hepes, 100 mM NaCl, 1 mM EDTA and 0.5 % Triton X-100 (pH 7.7)] before incubation with pre-cleared bovine brain lysate for 1 h at 4
• C with rotation. After washing, bound proteins were eluted by boiling in SDS/PAGE sample buffer. The samples were subjected to SDS/PAGE and either stained using Coomassie Blue or Western blotted. To investigate the effects of NEM and NO, beads were resuspended in HEN buffer and incubated for 30 min at 4
• C with NEM or NO donors either before or after incubation with brain lysate. This assay was performed as described previously [22] . NEM and NOR-1 were incubated with plate-bound GST-syntaxins for 30 min, then washed in PBS + 0.02 % Triton X-100 before addition of in vitro translated 35 S-radiolabelled Munc18-1. Binding was detected by liquid-scintillation counting as described previously [22] . Dose responses were as above but increasing concentrations of NO donors were added to wildtype syntaxin, for 30 min for NOR-1 and 45 min for SIN-1 (Smorpholinosydnonimine). NO release was monitored using the Griess assay reagent system kit (Promega).
Plate-based assay of GST-syntaxin/His-SNAP-25 binding
These assays were performed as described previously [17] , using 1 μg/well GST-syntaxin. To determine the effect of NEM on syntaxin, plate-bound GST-syntaxin was treated with 2 mM NEM for 30 min, before continuing with the standard binding assay. To determine the effect of NEM on SNAP-25, 200 nM His-tagged SNAP-25 was treated with 2 mM NEM and incubated for 30 min before adding 2 mM DTT (dithiothreitol) to quench excess NEM. The treated SNAP-25 was added to the bound syntaxin and binding was detected by ELISA as described previously [17] .
CD
GST-tagged fusion proteins were thrombin-cleaved to remove the GST tag. A Jasco-J810 spectropolarimeter was used for CD measurements in the far-UV region, from 190 to 260 nm. Spectra were recorded at protein concentrations of approx. 0.25 mg/ml in a cuvette of 1 mm path length in a temperature-controlled cell holder at 25
• C. Averaged CD signals, corrected for the buffer, were converted into mean residue weighted molar ellipticity as follows [23] :
Where C is the protein concentration in mM, θ is the measured ellipticity in millidegrees, n is the number of residues and l is the pathlength in cm.
MD (molecular dynamics) simulations
MD simulations of 15 ns each were performed on three different systems. The crystal structure of syntaxin 1a (PDB code 1DN1) was used in the simulations after manually removing the Munc18-1 component. The first system consisted of the unmodified wildtype syntaxin 1a structure. The second MD run replaced Cys 145 with nitrosocysteine. The replacement residue was modelled in the experimentally observed side-chain conformation that clashed least with neighbours, which was that seen in PDB entry 1BUW. In the third MD simulation the same cysteine residue was mutated to a tryptophan residue using PyMOL (http://pymol.sourceforge. net). PyMOL's inbuilt rotamer libraries [24] were used to choose the tryptophan rotamer clashing least with neighbouring residues and MODELLER [25] was used to relieve the remaining steric clashes. The Gromacs program [26] was used for the MD calculations using a force field appropriate for proteins in water. Modifications were made to the default Gromacs dictionary to generate an S-nitrosocysteine residue with the help of MOPAC 7 calculations [27] . Sodium ions were added to the simulation system to compensate for the net negative charge of the protein.
The simulation was carried out in a rectangular box with a minimal distance between solute and box edge of 0.7 nm and periodic boundary conditions were used. Only the stable part of the trajectories, the last 13.5 ns of each, was used for comparison between the three systems, using the average structure during the stable portion. Superposition was carried out using UCSF (University of California, San Francisco) Chimera software.
Live-cell imaging
Confocal laser scanning microscopy and image analysis in Neuro2a cells was performed as described previously [15] .
Cell culture, transfection and amperometry
Bovine adrenal chromaffin cells and HeLa cells were cultured and transfected as previously described [28] . Three independent preparations of chromaffin cells were used for each syntaxin mutant and amperometric recordings were made 3-5 days after transfection, as described previously [14] .
Statistics
Statistical analysis was performed using non-parametric MannWhitney tests.
RESULTS
S-Nitrosylation of exocytosis proteins
Owing to the labile nature of the nitrosothiol bond, S-nitrosylation is difficult to detect directly. However, in recent years, indirect thiol biotinylation assays have been developed to identify Snitrosylated proteins [21, 29] . In order to identify components of the exocytosis machinery that may be targets for S-nitrosylation, we used the biotin-loss technique [21] . This method is based on the selective labelling of free thiol groups on cysteine residues by biotin-HPDP; S-nitrosylated cysteine residues cannot be labelled, and so a reduced biotinylation signal after treatment with NO provides a readout of S-nitrosylation. Incubation of detergentsolubilized brain lysate with biotin-HPDP resulted in the incorporation of the biotin label into a large number of proteins, as detected by SDS/PAGE and subsequent avidin-HRP overlay ( Figure 1A , input). Biotinylated proteins in the lysates were then affinity-purified by binding to neutravidin-Sepharose ( Figure 1A , pull down). In the presence of the NO donor, GSNO, the intensity of the biotinylation signal was reduced for most proteins, indicating that S-nitrosylation had taken place. Lysate without any treatment showed no detectable avidin-HRP labelling ( Figure 1A ), confirming the specificity of the detection method. To identify components of the exocytosis machinery among these S-nitrosylated proteins, the pulldown samples were probed using antisera to various exocytosis proteins ( Figure 1B ). SNAP-25 and syntaxin 1 showed reduced GSNO-dependent binding to neutravidin-Sepharose, indicating that these proteins are Snitrosylated. In contrast, no reduction in biotinylation was seen with Munc18-1, VAMP 2 (vesicle-associated membrane protein 2) and 14-3-3, confirming that S-nitrosylation is selective for a subset of proteins even in crude brain extracts [30] . As SNAP-25 and syntaxin 1 form a stable complex, it was possible that these co-precipitated on the neutravidin beads and so were not independently nitrosylated. To address this, biotinylated/nitrosylated brain lysate was immunoprecipitated with a syntaxin 1 antibody. A reduction in biotinylation was evident after treatment with the NO donor, NOR-1, demonstrating that syntaxin was S-nitrosylated independently of SNAP-25 ( Figure 1C ). 
S-Nitrosylation of syntaxin 1a inhibits Mode 1 binding to Munc18
Incubation of recombinant proteins with NO donors has previously been observed to increase formation of the SNARE complex while inhibiting binding of Munc18-1 to GST-syntaxin 1a in vitro [31] . However, the mechanism of action of NO was entirely unclear in these experiments, as they were performed on protein mixtures and therefore the identity of the protein target(s) of NO was impossible to determine. Since we had identified syntaxin 1, but not Munc18-1, as a target for S-nitrosylation, this suggested that these reported effects might be mediated by S-nitrosylation of syntaxin 1a. To test this, the same GSTsyntaxin 1a construct used in the previous study [31] (encoding cytoplasmic domain residues 4-266) was pre-treated with NOR-1 or NEM before being incubated with untreated brain lysate, to ensure that these drugs could only act on syntaxin 1a ( Figure 2A , pre assembly). The sulfhydryl alkylating agent, NEM, was included as it was previously shown to mimic the effect of NO in inhibiting Munc18-1 binding to syntaxin 1a [31] and has the advantage of causing irreversible thiol modification, unlike NO. Both NOR-1 and NEM inhibited Munc18-1 binding to GSTsyntaxin 1a, as visualized by reduced levels of an approx. 67 kDa band in Coomassie-Blue-stained gels (Figure 2A ). This band was excised and analysed by MS and confirmed to be Munc18-1 (results not shown).
The binding of Munc18-1 to the GST-syntaxin 1a (4-266) construct in this assay is likely to occur mainly through the classical (Mode 1) binding to the closed conformation of syntaxin [32, 33] , as it is strongly inhibited by mutations that favour a more 'open' conformation [14] . In order for syntaxin 1 to bind to the other SNAREs and execute fusion, this inhibitory interaction must be dissociated to allow syntaxin to shift into an open conformation, although it is unclear what regulates this process.
Therefore we investigated whether NO could disrupt (postassembly) as well as inhibit (pre-assembly) the Munc18-1-syntaxin 1 interaction. Recombinant GST-syntaxin 1a was incubated with bovine brain extract and then treated with NOR-1 or NEM. Both treatments resulted in disruption of Munc18-1 binding to syntaxin (Figure 2A , post assembly). NEM treatment resulted in less binding in both pre-and post-assembly protocols, which may be explained by the transient and irreversible cysteine modifications caused by S-nitrosylation and NEM respectively. To test whether this Munc18-1 dissociation would facilitate syntaxin 1 binding to the other SNAREs, samples were Western blotted using antisera to SNAP-25 and VAMP 2. Treatments with both NOR-1 and NEM resulted in an increase in SNAP-25 and VAMP binding to syntaxin, which mirrored the reduction in Munc18-1 binding ( Figure 2B ).
To quantify these effects and to confirm that they were due solely to modification of syntaxin, recombinant protein binding assays using coated 96-well plates were performed. NOR-1 and NEM inhibited binding of in vitro translated 35 S-labelled Munc18-1 to GST-syntaxin 1a [22] by approx. 50 % and 75 % respectively ( Figure 2C ), consistent with the pulldown experiments. In contrast, the binding of purified His-tagged SNAP-25 to GSTsyntaxin 1a [17] was unaffected by NEM treatment of syntaxin ( Figure 2D ). This suggested that the increased SNAP-25 binding caused by NEM in the pulldown experiments from a complex mix of proteins was indirectly due to Munc18-1 dissociation from syntaxin 1, rather than a direct increase in affinity for SNAP-25. As SNAP-25 had also been identified as a potential target for nitrosylation, the same assay was used to investigate whether treating SNAP-25 with NEM affected the syntaxin 1-SNAP-25 interaction ( Figure 2D ). To do this, NEM was pre-incubated with recombinant SNAP-25 and then quenched with DTT before adding the SNAP-25 to GST-syntaxin 1a. This had no effect on the binding between SNAP-25 and syntaxin, therefore all subsequent work focussed on investigating syntaxin modification. To determine the concentration-dependence of the inhibitory effect of NO on the Mode 1 Munc18-1-syntaxin 1a interaction, binding assays were performed using a range of concentrations of structurally distinct NO donors, NOR-1 and SIN-1 ( Figure 2E ). Griess assays were performed in parallel to measure the amount of NO released by each concentration of NO donor during the incubations. NOR-1 and SIN-1 caused a similar dose-dependent inhibition of Munc18-1 binding at equivalent released NO concentrations ( Figure 2E ). This inhibition was saturable with NOR-1, yielding an IC 50 value of 1.1 + − 0.9 μM NO.
Binding of Munc18-1 to the SNARE complex is not inhibited by NO
In addition to the classical Mode 1 binding to the closed conformation of syntaxin, Munc18-1 can also bind to the extreme Nterminus of syntaxin (Mode 2), which enables its Mode 3 binding to the SNARE complex [15, [34] [35] [36] [37] [38] . As N-terminal truncation [15] and tagging [35] of syntaxin interferes with Mode 2/3 binding, the GST-syntaxin 1a (4-266) construct could not be used to determine the effect of NO/NEM on Munc18-1 binding to the SNARE complex. Instead, we used an affinity purification approach using GST-complexin [18] . Consistent with the selective binding of complexin to the SNARE complex [39] , syntaxin 1 and VAMP 2 were readily detected in pulldowns from brain lysate using GSTcomplexin, but not in GST controls ( Figure 3A) . The recovery of SNARE complexes was unaffected by treatment with NEM, reinforcing our finding that the syntaxin-SNAP-25 interaction is insensitive to this treatment. In contrast, the co-association of native Munc18-1 with the SNARE complex was strongly inhibited by NEM ( Figure 3A) . In this experiment, NEM was applied to (A) GST or GST-complexin (CPX) pre-bound to glutathione-coated beads was incubated with brain lysate, in the presence or absence of 1 mM NEM, and bound proteins were detected by Western blotting. Treatment with NEM had no effect on SNARE complex co-precipitation, but inhibited Munc18-1 binding. (B) GST-complexin (CPX) pre-bound to glutathione-coated beads was incubated with brain lysate in a two-stage protocol. In stage one, all samples were incubated with brain lysate, either untreated (control) or in the presence of 1 mM NOR-3 or NEM. After washing, samples were either eluted (−) or alternatively subjected to a second incubation with brain lysate in the presence or absence of 1 mM NOR-3 or NEM (stage two). NEM inhibits Munc18-1 co-precipitation with the SNARE complex (lanes 2 and 4) but not the capacity of the SNARE complex to interact with Munc18-1 when NEM is washed away (lane 6), whereas NOR-3 has no effect. IB, immunoblot.
the whole protein mixture, so it was not possible to determine whether the drug acted at the level of the SNARE complex, Munc18-1 or both. To address this issue and to determine whether NO would have the same effect, a two-stage incubation protocol was adopted. In stage one, all samples were incubated with brain lysate, either untreated or in the presence of NOR-3 or NEM. After washing, samples were either eluted or alternatively subjected to a second incubation with brain lysate in the presence or absence of NOR-3 or NEM (stage two). NEM treatment of the assembled complex in either stage inhibited Munc18-1 binding ( Figure 3B , compare lane 1 control with lanes 2 and 4), consistent with Figure 3(A) . Interestingly, selective pretreatment of this assembled complex did not prevent the subsequent binding of Munc18-1 from untreated brain lysate ( Figure 3B, lane 6) , indicating that the inhibitory action of NEM on Mode 3 binding acts at the level of Munc18-1 modification. In contrast, NOR-3 treatment had no effect on Munc18-1 binding to the SNARE complex, in keeping with the apparent resistance of Munc18-1 to S-nitrosylation (Figure 1) .
Model of NO action on syntaxin 1a: modification of Cys 145
Syntaxin 1a has only one cysteine residue in its cytoplasmic domain, Cys 145 , which is located toward the C-terminal end of the Hc helix. This cysteine residue is evolutionarily conserved in neuronal syntaxins (syntaxin 1a/b homologues) across a wide variety of organisms, but is absent from most non-neuronal homologues ( Figure 4A ). In the crystal structure of Munc18-1 bound via Mode 1 to the closed conformation of syntaxin 1a [40] Figure 4B , top panels). Therefore the inhibition of Mode 1 binding by NO/NEM modification of syntaxin observed in the present study is unlikely to be due to direct occlusion of a Munc18-1-binding site. Rather, modification of this Cys 145 is more likely to act allosterically, inducing a conformational change in syntaxin that indirectly affects Munc18-1 binding.
To investigate the potential structural consequences of Snitrosylation of Cys 145 , we performed MD simulations of wildtype and S-nitrosocysteine-modified syntaxin 1a, using atomic co-ordinates from the 1DN1 (PDB code) crystal structure. The average stable structures achieved over the last 13.5 ns of 15 ns simulations revealed little change to the Ha, Hb and Hc helices, with the two structures being basically superimposable in these regions ( Figure 4B , bottom left-hand panel). However, Cys 145 Snitrosylation affected the local structure of syntaxin C-terminal to this residue, resulting in movement of the linker region that connects Hc to the H3 SNARE helix, and also alterations in the orientation of the C-terminal end of the SNARE motif itself. Disruption of the Cys 145 -Ile 202 hydrophobic interaction by Snitrosylation in the simulation destabilized the association of the H3a helix of the SNARE motif with the Hc helix, which in turn prevented Leu 169 in the linker from making its normal contact with His 199 in the H3a helix, thus reorienting the linker domain. Interestingly, mutations in the linker domain are used to create the 'open' syntaxin mutant, which exhibits reduced Mode 1 Munc18-1 binding [32] . In addition, the S-nitrosylation-induced repositioning of the H3c subdomain, a 5-residue helix near the C-terminus that makes multiple contacts with the central cavity of Munc18-1, would have profound effects on Mode 1 Munc18-1 binding, as mutation of a single residue in the H3c helix, Ile 233 , strongly inhibits this interaction [14] .
Effects of mutating Cys 145 on syntaxin structure and function in vitro
To analyse the effects of a Cys 145 -specific modification on syntaxin, we set out to create mutant proteins that would mimic or be resistant to S-nitrosylation (analogous to the phosphomimetic and non-phosphorylatable mutants used in protein phosphorylation studies). Cysteine-serine substitutions are commonly used to create non-S-nitrosylatable proteins [11] . Furthermore, syntaxins 2 and 3 both contain a serine residue at position 145 in an otherwise highly conserved region ( Figure 4A ), so it was assumed that a C145S mutation would not affect the overall structure or function of syntaxin 1a. In contrast, 'nitrosomimetic' mutants have no precedent within the literature. We therefore generated mutations that might approximate an S-nitrosylated cysteine residue, using substitutions to methionine and tryptophan residues (C145M, C145W). Methionine was chosen as it preserves the sulfur atom of cysteine, but replaces the attached hydrogen with a methyl group, which may resemble an NO group attached to the sulfur. However, as this methyl group is still less bulky than NO, we also used a tryptophan substitution, reasoning that this large aromatic amino acid may more effectively mimic modification by NO and NEM. MD simulations of the C145W mutant revealed structural alterations to the linker region and destabilization of the H3c helix ( Figure 4B , bottom right-hand panel), the same regions altered in the Cys 145 -S-nitrosylated simulation, suggesting that C145W might be a suitable nitrosomimetic mutant. Therefore these Cys 145 mutations were introduced into GST-syntaxin 1a (4-266) to enable biochemical analysis of the mutant proteins.
If Cys 145 is the sole nitrosylation site in the protein, then mutation of this residue to any other amino acid should inhibit biotin-HPDP labelling in the biotin-loss assay. To test this, wild-type and C145W mutant GST-syntaxin 1a were purified and then their GST tags were removed by thrombin cleavage. These were then used in the biotin-loss assay, along with purified recombinant His-tagged NSF as a positive control ( Figure 5A ). Wild-type recombinant syntaxin exhibited robust biotinylation that was reduced by NO treatment, similar to that seen for the native brain protein (Figure 1) . NSF also showed clear NO-inhibited biotinylation, thus further confirming the validity of the biotin-loss assay. In contrast, biotinylation of C145W syntaxin was barely detectable ( Figure 5A ). Therefore Cys 145 is indeed an Snitrosylation site, at least in vitro.
We also investigated the effect of Cys 145 mutations on Mode 1 Munc18-1 binding ( Figure 5B ). The C145S mutant bound Munc18-1 to the same extent as wild-type syntaxin 1a, but was unaffected by NOR-1 and NEM. This confirmed that the inhibitory effect of these drugs on Munc18-1 binding was entirely mediated via modification of syntaxin 1a at Cys 145 , consistent with the biotin-loss assay in Figure 5(A) . The C145M and C145W mutants exhibited reduced Munc18-1 binding, similar to the inhibition of wild-type syntaxin by NOR-1 and NEM respectively ( Figure 5B ). This further supports the idea that S-nitrosylation of Cys 145 regulates Mode 1 Munc18-1 binding and suggests that these mutants may indeed represent nitrosomimetic versions of syntaxin. The reduction in Munc18-1 binding by C145W in this pulldown assay was similar to that seen when the 'open' (Figure 5B ) and I233A mutations (results not shown) were introduced into the same GST-syntaxin 1a (4-266) construct. In order to quantify Munc18-1 binding, assays were performed using GSTtagged syntaxins bound to glutathione-coated plates and incubated with 35 S-labelled in-vitro-translated Munc18 ( Figure 5C ). This revealed a 62 % and 87 % reduction in Munc18-1 binding to C145M and C145W respectively, similar to the inhibition of binding seen with NOR-1 and NEM (60 % and 80 % respectively). As no inhibition of Munc18-1 binding was seen with the C145S mutant, this effect is specific to nitrosomimetic residues and not simply a consequence of mutating Cys 145 . All mutants exhibited similar levels of SNAP-25 binding (Figure 5D ), consistent with the observation (Figure 2 ) that NEM does not affect this interaction. The finding that SNAP-25 binding was normal in the nitrosomimetic mutants suggested that the observed reduction in Munc18-1 binding was unlikely to be due to gross conformational defects in the recombinant mutant proteins. However, to test this directly, the proteins were analysed by CD spectroscopy after removal of their GST tags. Wild-type, C145M and C145W proteins exhibited superimposable spectra, confirming that there were no major changes in the structural integrity of the nitrosomimetic mutants ( Figure 5E ).
Effect of syntaxin 1a Cys 145 mutants on the Munc18-1 interaction in living cells
To investigate the relevance of Cys 145 for Munc18-1 binding in a cellular context, we introduced non-nitrosylatable (C145S) and nitrosomimetic (C145W) mutations into mCerulean-tagged full-length syntaxin 1a (residues 1-288). These were then cotransfected with EYFP (enhanced yellow fluorescent protein)-tagged Munc18-1 in N2A (neuroblastoma 2A) cells and visualized by fluorescence microscopy ( Figure 6A ). Wild-type syntaxin 1a co-localized with Munc18-1 at the plasma membrane and also in perinuclear areas, as previously shown [15] . The C145S mutant had an identical distribution, consistent with the similar behaviour of this mutant to wild-type syntaxin 1a in all in vitro binding assays. In contrast, diffuse cytoplasmic staining of Munc18-1 was evident upon co-expression of the C145W nitrosomimetic mutant and treatment of wild-type syntaxin 1a with NEM (note the red hue (A) Recombinant wild-type and C145W mutant syntaxin 1a, and NSF, were subjected to the biotin-loss assay in the presence or absence of 1 mM GSNO. Samples were run on SDS/PAGE and detected by immunoblotting (IB, left-hand panel) or avidin overlay (right-hand panel). Wild-type syntaxin and NSF showed NO-inhibitable biotinylation, indicative of direct S-nitrosylation. In contrast, C145W exhibited negligible biotin labelling, suggesting that Cys 145 is the S-nitrosylation site in syntaxin 1a. (B) GST-tagged wild-type and mutant syntaxins pre-bound to glutathione-coated beads were treated with 1 mM NEM or NOR-1 before incubation with brain lysate. Bound proteins were separated by SDS/PAGE and detected using Coomassie Blue stain. C145M, C145W and open mutant syntaxins all show reduced Munc18-1 binding, similar to that seen when wild-type GST-syntaxin is pre-incubated with 1 mM NEM or NOR-1. C145S syntaxin is insensitive to NO or NEM pre-treatment. (C) GST-tagged wild-type and mutant syntaxins or GST pre-bound to glutathione-coated plates were incubated with 35 S-labelled Munc18-1. Bound Munc18-1 determined by scintillation counting was reduced in C145M, C145W and open mutant syntaxins, but not C145S. (D) All of the GST-tagged proteins showed equivalent binding to His-SNAP-25, as determined by ELISA. (E) The GST-tag was removed from wild-type syntaxin and the nitrosomimetic C145M and C145W mutants using thrombin. These proteins were then analysed by CD spectroscopy. Binding data are shown as means + − S.E.M. wt, wild-type; Syx, syntaxin.
in merged panels in Figure 6A ). Strikingly, this effect of NEM was completely abolished in the C145S mutant ( Figure 6A ), indicating that the inhibition of syntaxin 1a-Munc18-1 co-localization by NEM is absolutely dependent on Cys 145 modification. In order to quantify the co-localization of Munc18-1 with syntaxin in the whole cell, rather than in a single confocal slice, the intensity for each channel in each voxel was determined (shown in the twodimensional histogram panel, with a colour scale representing frequency). The residual map displays weighted residuals from the line fit to the histogram, thus indicating fluorescence channel covariance. The diffuse cytoplasmic purple hue evident in the NEMtreated wild-type Syx 1−288 [the full-length syntaxin 1a (residues 1-288)] and the C145W samples corresponds to regions where EYFP-Munc18-1 is not co-variant with mCerulean-syntaxin fluorescence. Analysis of these data from multiple cells revealed a significant decrease in the correlation coefficient for NEM-treated wild-type Syx 1−288 and C145W-expressing cells, but no effect of NEM on C145S-transfected cells ( Figure 6B) .
It was notable that significant plasma membrane staining of Munc18-1 remained in C145W-expressing cells, but not in NEM-treated wild-type-expressing cells. To determine whether this residual Munc18-1 was actually interacting with the C145W protein, we used FLIM (fluorescence lifetime imaging microscopy). A single fluorescence lifetime of the donor, mCerulean-Syx 1−288 , was observed in the absence of an energy acceptor ( Figure 7A ; top right-hand panel), with a mean value of 2288 + − 40 ps. When co-expressed with the EYFP-Munc18-1 FRET (Förster resonance energy transfer) acceptor, a reduction in the mean mCerulean-Syx 1−288 donor fluorescence lifetime occurred, consistent with FRET due to interaction of the two tagged proteins [15] . This is visualized in the FLIM map as yellow/green staining, as opposed to the blue hue with Syx 1−288 alone (quantified in Figure 7B ). Treatment of Syx 1−288 with NEM abolished the detectable interaction with Munc18-1 on the cell surface, as indicated by the loss of the short fluorescence lifetime (note blue plasma membrane staining, similar to that seen in the absence of Munc18-1). In contrast, identical NEM treatment of the C145S mutant did not abolish its interaction with Munc18-1 at the plasma membrane. Similarly, the Munc18-1 interaction at the cell surface was preserved in the C145W nitrosomimetic mutant. These results suggest that the Mode 1 binding of Munc18-1 to syntaxin 1a is not essential for the interaction at the plasma membrane. The abolition of this interaction by NEM probably reflects its inhibitory action on multiple binding modes via effects on both syntaxin 1a and Munc18-1, as seen in our in vitro binding assays ( Figure 3 ). Consistent with this need to act on both proteins, NEM does not abolish the plasma membrane interaction when syntaxin 1a cannot be modified (C145S).
Effect of syntaxin 1a Cys 145 mutants on exocytosis
In adrenal chromaffin cells, overexpression of syntaxin mutants defective in Mode 1 Munc18-1 binding alters single vesicle release kinetics, but has no effect on the frequency of exocytosis events [14] . As nitrosomimetic (but not non-nitrosylatable) Cys Figure 8A ). However, C145W overexpression resulted in increased rise and fall times, half-width and quantal size, as did overexpression of open syntaxin used as a control ( Figure 8A ). As C145W and C145S differ only in the nature of the Cys 145 mutation, this indicates a nitrosomimetic-residue-specific effect of the mutant on exocytosis, consistent with the Munc18-1 binding results. In addition, as there was no difference between the mutants in protein expression level ( Figure 8B ; performed in HeLa cells due to the low transfection efficiency of chromaffin cells), these effects were not due to differential stability of the mutant proteins. Therefore overexpression of the C145W mutant syntaxin increases quantal size and slows the kinetics of individual exocytotic fusion events, consistent with the impaired Mode 1 Munc18-1-binding characteristics of this nitrosomimetic mutant.
DISCUSSION
S-Nitrosylation has emerged as an important mechanism by which NO modulates various physiological processes, including exocytosis. However, identification of the relevant substrates has been hampered by the technical difficulty of detecting Snitrosylated proteins within cellular extracts. The development of indirect thiol biotinylation assays in recent years [21, 29] has facilitated identification of a number of potential targets, but very few examples exist where the molecular mechanism by which site-specific S-nitrosylation regulates protein structure and function is understood. In the present study we have used the biotin-loss technique to demonstrate specific NO-induced S-nitrosylation of both endogenous syntaxin 1 from brain extracts and recombinant syntaxin 1a, consistent with findings using purified vesicle preparations [21] . Importantly, syntaxin 1 has been shown to be endogenously S-nitrosylated in rat brain in vivo in the absence of NO donors, indicating that this modification occurs physiologically [41] . Using a combination of biochemical, cellular and molecular modelling approaches we have shown that modification of the sole S-nitrosylation site in the cytoplasmic domain of syntaxin 1a, Cys 145 , specifically inhibits the classical mode of Munc18-1 binding. Our development of a novel nitrosomimetic mutant approach (analogous to the phosphomimetic mutants that underpin many protein phosphorylation studies) was particularly important in the present study, and may be of more general use to study the effect of site-specific S-nitrosylation in vivo. Although a 'consensus sequence' for S-nitrosylation is difficult to define, S-nitrosocysteines are typically located within areas of positive charge and are often close to aromatic amino acids in buried regions [30] . The sequence surrounding Cys 145 in syntaxin 1a fits these criteria and is highly conserved (YRXRCK) in all neuronal syntaxins throughout evolution ( Figure 4A) . Interestingly, the syntaxin family as a whole is relatively cysteinepoor, for example syntaxin 3 contains no cysteine residues. The retention of a single cysteine residue in the cytoplasmic domain of syntaxin 1a in various species suggests a specific function; potentially regulation by S-nitrosylation, or by other modifications such as oxidation, glutathionylation or palmitoylation. It is interesting to note that, although generally absent from non-neuronal syntaxins, the Cys 145 -homologous residue is also found in syntaxins 11 and 19. Little is known about the function of syntaxin 19, but syntaxin 11 is involved in regulated exocytosis in cytotoxic lymphocytes [42] . As syntaxin 4 also contains a cysteine residue in its Hc domain (albeit 11 residues upstream of the Cys 145 -homologous residue in syntaxin 1a, see Figure 4A ), and is involved in regulated exocytosis in various cell types, it is tempting to speculate that cysteine modification may be a specific regulatory mechanism for syntaxins involved in regulated exocytosis.
Recently, our understanding of Munc18-1 function has been dramatically illuminated by the discovery that, in addition to its originally discovered (Mode 1) interaction with the closed conformation of syntaxin 1 [33] , Munc18-1 can also bind to an Nterminal peptide of syntaxin 1a (Mode 2) [15] . This Mode 2 interaction is essential for Munc18-1 binding to the SNARE complex (Mode 3) [35] , which facilitates membrane fusion [34] . Although Mode 2 and 3 interactions are common to diverse SM (Sec1/Munc18-like)-syntaxin pairs, the Mode 1 interaction has, to date, only been documented in homologues involved in regulated exocytosis, including mammalian Munc18-1 and Munc18c, and Caenorhabditis elegans UNC-18 [37, 38, 43] . Disruption of the Mode 1 interaction via transition to the open conformation of UNC-64 (C. elegans syntaxin 1) has been suggested to be part of the priming process that leads to synaptic vesicle docking and fusion in vivo [44, 45] . The finding in the present study that S-nitrosylation of syntaxin 1a at Cys 145 specifically antagonizes Mode 1 binding suggests that post-translational modification of this cysteine residue could be a mechanism to regulate this potentially inhibitory interaction, thereby facilitating the interaction of syntaxin with cognate SNAREs, and subsequently Munc18-1 in the Mode 2/3 interaction, to execute membrane fusion. Alternatively, as Mode 1 binding of Munc18-1 to the closed conformation of syntaxin has recently been shown to play a positive role in Rab3-dependent vesicle docking [18, 46, 47] , Snitrosylation of syntaxin could potentially also act as an inhibitory regulator of this early stage of the exocytosis process in some cell types. PUFAs (polyunsaturated fatty acids) have recently been shown to inhibit Mode 1 binding, but by a distinct mechanism involving a major conformational change detectable by CD spectroscopy, which probably results in syntaxin assuming a more open conformation [48] . Interestingly, PUFA supplementation increased S-nitrosylation of endogenous syntaxin 1 in rat hippocampus in vivo [41] , suggesting that opening of syntaxin via PUFAs may increase the probability of Cys 145 modification, providing a potential synergistic link between these two regulatory mechanisms.
Analysis of exocytosis by amperometry in adrenal chromaffin cells treated with NO donors reveals two distinct effects: an overall inhibition of exocytosis and a slowing of the release kinetics and increased quantal size in the remaining individual fusion events [9] . Intriguingly, overexpression of the C145W nitrosomimetic syntaxin 1a mutant similarly slows release kinetics and increases quantal size. This suggests a potential link between NO and syntaxin in exocytosis via S-nitrosylation of Cys 145 . Such a regulatory mechanism may help to rationalize the confusing literature on the effects of NO on exocytosis, where both stimulatory and inhibitory actions are commonly reported, even in the same cell type. S-Nitrosylation of NSF, and the consequent depletion of free SNAREs able to engage in fusion, is likely to be important for the inhibitory effects of NO [13] . However, it is difficult to see how NSF inhibition could explain the stimulation of synaptic vesicle and insulin granule exocytosis by NO [5, 6] or the effect on release kinetics in chromaffin cells [9] . We suggest that S-nitrosylation of syntaxin at Cys 145 may be a mechanism by which NO can cause such positive effects, by switching off Mode 1 Munc18-1 binding, thereby facilitating syntaxin 1 engagement with the fusion machinery. It is tempting to speculate that this may contribute to the role of NO as a retrograde messenger in synaptic plasticity [10] , with post-synaptically generated NO acting locally at the presynaptic active zone to relieve the constraint of Mode 1 Munc18-1 binding, thus increasing the release probability of subsequent stimuli.
In summary, the results of our present study provide a novel molecular mechanism for switching between distinct syntaxinMunc18 binding modes: S-nitrosylation of Cys 145 in syntaxin 1a. Several distinct lines of evidence support this model, ranging from in silico molecular modelling, through in vitro protein-protein interaction assays, to cellular studies of protein interactions and exocytosis. Two key questions arise from the present study: (i) is this regulatory mechanism physiologically important in vivo, and (ii) is it restricted to the syntaxin 1-Munc18-1 SM pairing? Further work capitalizing on the conserved nature of Cys 145 in genetically tractable model organisms ( Figure 4 ) is required to address these issues rigorously. The use of the nitrosomimetic mutant approach described in the present study may facilitate such future studies into the role of site-specific S-nitrosylation on syntaxin function in vivo.
